Gujarat Themis Biosyn Limited has informed the Exchange about Commencement of commercial production/operations
GUJTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Themis Biosyn has started commercial production at its newly set up API manufacturing plant located at 69/C GIDC Industrial Estate, Vapi, Gujarat, effective May 6, 2025. The facility is a multi-purpose plant designed for both synthetic and fermentation-based production of Active Pharmaceutical Ingredients (APIs) and Intermediates for the pharmaceutical industry. The company says the plant will support its forward integration plans and strengthen its presence in export markets, particularly the United States and Europe. No revenue figures, production capacity numbers, or specific order details were disclosed in the filing.
This is an operational milestone that adds new manufacturing capacity and positions the company for growth in regulated overseas markets, which could be positive for long-term revenue. However, without disclosed volumes, capacity, or order book details, the immediate stock impact is likely to be limited.